Selected application of peptide molecules as pharmaceutical agents and in cosmeceuticals

Expert Opin Biol Ther. 2019 Dec;19(12):1275-1287. doi: 10.1080/14712598.2019.1652592. Epub 2019 Aug 13.

Abstract

Introduction: Peptide molecules are being vastly investigated as an emerging class of therapeutic molecules in recent years. Currently, 60 peptides have been approved by the US Food and Drug Administration (FDA), and more would enter the market in near future. Peptides have already opened their ways into cosmeceutical and food industries as well.Areas covered: Antibodies, vaccines, and antimicrobial agents are the major classes of therapeutic peptides. Additionally, peptides may be employed in drug development to support cell penetration or targeting. The interest in antimicrobial peptides is surging due to the increasing risk of antibiotic-resistant pathogens. Peptide vaccines with their significant advantages compared with traditional vaccines, are expected to find their place in coming years, especially for cancer, microbial and allergen-specific immunotherapy. The usage of peptides in cosmeceuticals is also growing rapidly.Expert opinion: Peptide synthesis has become accessible, and advances in peptide engineering, sequencing technologies, and structural bioinformatics have resulted in the rational designing of novel peptides. All these advancements would lead to the more prominent roles of peptides in the mentioned areas. In this review, we discuss applications of peptides in different fields including pharmaceuticals, cosmeceuticals, besides the critical factors in designing efficient peptide molecules.

Keywords: Peptide molecules; cosmeceuticals; drug design; peptide vaccine; pharmaceuticals.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Infective Agents
  • Cosmeceuticals / chemistry
  • Cosmeceuticals / pharmacology*
  • Humans
  • Peptides / chemistry
  • Peptides / pharmacology*
  • Vaccines

Substances

  • Anti-Infective Agents
  • Cosmeceuticals
  • Peptides
  • Vaccines